The Stages of Recovery

The Transtheoretical Model: the clinical framework behind the stages

The most widely used framework for understanding readiness to change is the Transtheoretical Model, developed by psychologists James Prochaska and Carlo DiClemente in the 1980s. The model describes five stages through which people move when changing a deeply ingrained behavior. It has been validated across substance use disorders, smoking, and other health behaviors, and it is referenced in SAMHSA's Treatment Improvement Protocol 35 and in the National Institute on Drug Abuse's principles of addiction treatment.

The practical value of this framework is that it explains why the same intervention, say a direct push toward treatment, produces completely different results depending on where a person is in the stages. A person in precontemplation responds to that push by digging in. A person in preparation responds by accelerating action. The framework is a tool for calibrating support, not a label for judging effort.

Precontemplation and contemplation: before change begins

In precontemplation, the person does not view their substance use as a problem worth addressing, or they believe change is not possible, or the perceived benefits of continuing outweigh the perceived costs. Many people arrive at a first clinical conversation in this stage, brought by a family member, an employer, or a court. The clinical approach at this stage is not to argue or apply pressure, but to build relationship, reduce shame, and keep the door to help open.

Contemplation begins when ambivalence sets in. The person recognizes that substances are causing real harm but is not yet committed to acting. The defining feature of this stage is the internal tug of war: reasons to change and reasons to stay the same feel roughly balanced. Motivational interviewing is most powerful here because it draws out the person's own reasons for change rather than imposing them from outside. The goal is to shift the decisional balance by exploring costs and benefits honestly, not by delivering arguments the person has already heard.

Preparation and action: entering treatment

Preparation is the turning point: the person intends to act within the next 30 days and begins making concrete plans, researching programs, telling family, arranging logistics. This is when a call to an admissions line most commonly happens. The clinical work at this stage is to support the forming commitment, address practical obstacles, and translate intention into a concrete start.

Action is the acute treatment phase. In substance use disorder terms, this means starting at PHP, IOP, or standard outpatient, beginning medication-assisted treatment where clinically indicated, engaging in individual and group therapy, and building a recovery community connection. This is the most demanding stage because the person is doing the most visible, intensive work.

• Entering a structured outpatient level matched to clinical need (PHP, IOP, or OP)
• Completing the ASAM Criteria intake assessment and establishing a treatment plan
• Beginning individual therapy, group therapy, and relapse prevention planning
• Starting medication-assisted treatment for opioid or alcohol use disorder where appropriate
• Initiating recovery community involvement: 12-step, SMART Recovery, or other peer support
• Beginning family programming with consent

Maintenance and sustained recovery

Maintenance begins once the acute work of early treatment is complete and the focus shifts to sustaining what was built. SAMHSA defines maintenance as beginning after six months of sustained change. Clinical contact steps down: most clients move from IOP to standard outpatient and then to continuing care groups and periodic individual therapy. Recovery community participation becomes the primary daily structure outside work and family.

Relapse risk remains real during maintenance, particularly in the first year, when the brain is still completing neurological restoration and old triggers retain their potency. A written relapse prevention plan, consistent peer support, and the ability to step back up to more intensive outpatient care quickly are the three tools that most reliably protect this phase.

• Stepping down from IOP to standard outpatient as stability increases
• Active relapse prevention planning with written trigger identification and coping strategies
• Regular recovery community participation: meetings, peer support, or alumni programming
• Ongoing treatment of co-occurring mental health conditions
• Rebuilding employment, relationships, and daily structure

The clinical phases mapped to time

Beyond the Stages of Change, addiction medicine describes granular clinical phases tied to specific timeframes. The stabilization phase, roughly weeks one through four, involves physical and clinical stabilization: detox is complete, acute withdrawal has diminished, the treatment plan is in place, and MAT is established. Early recovery, months one through six, is the active clinical phase where step-down progresses through the levels of care and the real therapeutic work deepens. Sustained recovery, months six through 24, sees previously built structures become more self-sustaining with decreased daily clinical input. Long-term recovery, year two and beyond, involves clinical contact that may be occasional while recovery community remains active.

Understanding these clinical phases helps clients and families calibrate expectations. The first three months are the highest-risk window and require the most intensive support. By year five, what SAMHSA describes as late recovery, the active 'I am recovering' framing often gives way to a more integrated sense of identity in which the substance use disorder is one chapter in a life, not its defining feature.

Where relapse fits in the stages

The original Transtheoretical Model included relapse as a distinct stage. Current clinical revisions treat it instead as a re-entry point into earlier stages rather than a permanent setback. The National Institute on Drug Abuse reports that relapse rates for substance use disorders are similar to those for diabetes, hypertension, and asthma, ranging from 40 to 60 percent across studies. This comparison is clinically accurate and matters because it reframes relapse as a clinical event requiring plan adjustment, not a moral failure requiring judgment.

When relapse occurs, the clinical response is to reassess the stage, step care back up to the appropriate level of intensity, update the relapse prevention plan with new trigger data, and address any undertreated co-occurring conditions that contributed to the return to use. Most people who reach sustained long-term recovery experienced at least one setback along the way.